New DGK-α and DGK-ζ inhibitors outlined by Gossamer Bio
July 18, 2024
Gossamer Bio Inc. has divulged diacylglycerol kinase α (DGK-α) and/or diacylglycerol kinase ζ (DGK-ζ) inhibitors reported to be useful for the treatment of cancer and viral infections.